In this phase of type 1 diabetes, insulin therapy plus nutritional support is crucial for driving the patient from ketoacidosis and hyperglycemia to euglycemia and, thus, preserving residual β-cells’ endogen function. This evidence concerns the gene INS and Hyperglycemia.